Business
TGA proposes over-the-counter sales of CBD products – Small Caps
In a move that would appear to enthuse the ASX-listed cannabis stocks, the Therapeutic Goods Administration (TGA) has announced an interim decision to reclassify cannabidiol (CBD) products so they can be purchased over the counter at pharmacies.
In a move that would appear to enthuse the ASX-listed cannabis stocks, the Therapeutic Goods Administration (TGA) has announced an interim decision to reclassify cannabidiol (CBD) products so they can be purchased over the counter at pharmacies.
The TGAs provisional ruling entails the down-scheduling of low dose CBD products from Schedule 4 to Schedule 3 of the Poisons Standard. This means companies can apply to register their applicable products to be available through a pharmacist, without th…
-
Noosa News21 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General21 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General17 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General11 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore